{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pulmonary Arterial Hypertension: An Overview
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Recognize the pathophysiology that characterizes PAH.
- Select the appropriate assessment strategies for PAH.
- Identify the appropriate pharmacologic management of PAH.
- Choose the applicable nursing interventions for patients who have PAH.
Learning Outcomes
75% of participants will demonstrate knowledge of the pathophysiology, clinical manifestations, diagnostics, pharmacological treatment of and nursing interventions for pulmonary arterial hypertension (PAH) by achieving a minimum score of 70% on the outcomes-based posttest.Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$21.95
Credits:
- ANCC 2.0 CH / 1.0 APH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: N1121B
Published: Nov 2021
Expires: 9/6/2024
Sources:
Nursing2024
Required Passing Score: 8/10 (80%)